A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/15 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2481466
The present invention provides a therapeutic agent of kidney cancer, which comprises FK228 of the formula (I) or a salt thereof. FK228 or a salt thereof, which is an active ingredient in the present invention, shows a superior antitumor activity in vivo against kidney cancer.
La présente invention concerne un agent thérapeutique du cancer du rein, à base du FK228 représenté par la formule générale (I), ou de l'un de ses sel. En l'occurrence, ce FH228, ou le sel considéré, qui constituent le principe actif de la présente invention, font preuve, in vivo, d'une activité antitumorale accrue contre le cancer du rein.
Bates Susan E.
Naoe Yoshinori
Astellas Pharma Inc.
Department Of Health And Human Services The Government Of The United States Of America Represented By Th
Fujisawa Pharmaceutical Co. Ltd.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Depsipeptide for therapy of kidney cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Depsipeptide for therapy of kidney cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Depsipeptide for therapy of kidney cancer will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1576151